Suppr超能文献

消费者保护政策与实践回顾及其在第三方公司医院源数据聚合与分析中的应用

A Policy and Practice Review of Consumer Protections and Their Application to Hospital-Sourced Data Aggregation and Analytics by Third-Party Companies.

作者信息

Rahimzadeh Vasiliki

机构信息

Stanford Center for Biomedical Ethics, Stanford University, Stanford, CA, United States.

出版信息

Front Big Data. 2021 Feb 12;3:603044. doi: 10.3389/fdata.2020.603044. eCollection 2020.

Abstract

The Office of the National Coordinator for Health Information Technology estimates that 96% of all U.S. hospitals use a basic electronic health record, but only 62% are able to exchange health information with outside providers. Barriers to information exchange across EHR systems challenge data aggregation and analysis that hospitals need to evaluate healthcare quality and safety. A growing number of hospital systems are partnering with third-party companies to provide these services. In exchange, companies reserve the rights to sell the aggregated data and analyses produced therefrom, often without the knowledge of patients from whom the data were sourced. Such partnerships fall in a regulatory grey area and raise new ethical questions about whether health, consumer, or health and consumer privacy protections apply. The current opinion probes this question in the context of consumer privacy reform in California. It analyzes protections for health information recently expanded under the California Consumer Privacy Act ("CA Privacy Act") in 2020 and compares them to protections outlined in the Health Information Portability and Accountability Act ("Federal Privacy Rule"). Four perspectives are considered in this ethical analysis: 1) standards of data deidentification; 2) rights of patients and consumers in relation to their health information; 3) entities covered by the CA Privacy Act; 4) scope and complementarity of federal and state regulations. The opinion concludes that the CCPA is limited in its application when health information is processed by a third-party data aggregation company that is contractually designated as a business associate; when health information is deidentified; and when hospital data are sourced from publicly owned and operated hospitals. Lastly, the opinion offers practical recommendations for facilitating parity between state and federal health data privacy laws and for how a more equitable distribution of informational risks and benefits from the sale of aggregated hospital data could be fostered and presents ways both for-profit and nonprofit hospitals can sustain patient trust when negotiating partnerships with third-party data aggregation companies.

摘要

美国卫生信息技术国家协调办公室估计,美国96%的医院使用基本的电子健康记录,但只有62%的医院能够与外部供应商交换健康信息。电子健康记录系统之间的信息交换障碍对医院评估医疗质量和安全所需的数据汇总和分析构成了挑战。越来越多的医院系统正在与第三方公司合作提供这些服务。作为交换,这些公司保留出售汇总数据及其分析结果的权利,而数据来源的患者往往对此并不知情。这种合作关系处于监管灰色地带,并引发了关于健康、消费者或健康与消费者隐私保护是否适用的新伦理问题。本意见书在加利福尼亚州消费者隐私改革的背景下探讨了这个问题。它分析了2020年根据《加利福尼亚州消费者隐私法》(“加州隐私法”)最近扩大的对健康信息的保护,并将其与《健康保险流通与责任法案》(“联邦隐私规则”)中概述的保护措施进行了比较。在这种伦理分析中考虑了四个观点:1)数据去识别化标准;2)患者和消费者对其健康信息的权利;3)加州隐私法涵盖的实体;4)联邦和州法规的范围和互补性。该意见书得出结论,当健康信息由合同指定为业务合作伙伴的第三方数据汇总公司处理时;当健康信息被去识别化时;以及当医院数据来自公有公立医院时,《加州消费者隐私法》的适用范围有限。最后,该意见书就促进州和联邦健康数据隐私法之间的平等以及如何促进从出售汇总医院数据中更公平地分配信息风险和利益提出了实际建议,并提出了营利性和非营利性医院在与第三方数据汇总公司谈判合作关系时维持患者信任的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/7931961/1287955322c3/fdata-03-603044-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验